Structure (9316439a 35e3 4777 Ae09 28a1cc6d3d4f 01)
Nifedipine Tablet, Extended Release
Product Images NDC 70771-1366
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 70771-1366). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Container Label 30 mg (9316439a 35e3 4777 Ae09 28a1cc6d3d4f 02)
This is a product description for Nifedipine Extended-Release Tablets. These tablets contain 30mg of Nifedipine USP and should be swallowed whole, not bitten or divided. The usual dosage is available in the package insert. These tablets should be stored at 20° to 25°C (68° to 77°F), protected from light and moisture, and dispensed in tight, light-resistant containers. The tablets come in a bottle of 100 and are manufactured by Cadila Healthcare Ltd. in India.*
Container Label 60 mg (9316439a 35e3 4777 Ae09 28a1cc6d3d4f 03)
This is a description of NIFEdipine extended-release tablets manufactured by Cadila Healthcare Ltd., India. Each film-coated tablet contains 60mg of Nifedipine USP, and they are only available through a prescription. The recommended dosage should be followed as stated in the package insert. These tablets should be stored in a controlled room temperature of 20° to 25°C and kept away from moisture and light. The tablets should be swallowed whole and not bitten or divided. Additionally, these tablets must be kept away from the reach of children and dispensed in tight and light-resistant containers.*
Container Label 90 mg (9316439a 35e3 4777 Ae09 28a1cc6d3d4f 04)
This is a description of Nifedipine Extended-Release Tablets. Each film-coated extended-release tablet contains 90mg of Nifedipine USP, and should be swallowed whole without biting or dividing. The recommended dosage is available in the package insert. The tablets should be stored at 20°-25°C (68°-77°F) in tight, light-resistant containers. They should be protected from light and moisture, and kept out of reach of children. These tablets are manufactured by Cadila Healthcare Ltd in Ahmedabad, India.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
